DBV Technologies (DBVT) Other Operating Expenses (2020 - 2026)
DBV Technologies (DBVT) posted quarterly Other Operating Expenses of $5.5 million for Q2 2026, up 1275.0% year-on-year from $400000.0 in Q2 2025, and up 12.24% on a QoQ basis from $4.9 million in Q1 2026.
DBV Technologies (DBVT) Other Operating Expenses (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Other Operating Expenses for 7 consecutive years, with $5.5 million the latest figure, recorded in Q2 2026.
- Quarterly Other Operating Expenses rose 1275.0% year-over-year to $5.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.9 million (up 701.24% YoY) and the FY2025 annual result came in at $3.2 million, up 21.17% from the prior year.
- Other Operating Expenses improved to $5.5 million in Q2 2026 per DBVT's latest filing, from $4.9 million in the prior quarter.
- Over the last five years, Other Operating Expenses for DBVT reached as high as $5.5 million in Q2 2026 and fell as low as -$51000.0 in Q4 2022.
- A 5-year average of $1.1 million and a median of $591000.0 in 2023 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses tumbled 103.67% — and 2023, when it surged 1717.65%.
- Year by year, Other Operating Expenses stood at -$51000.0 in 2022, then jumped by 1717.65% to $825000.0 in 2023, then plunged by 52.0% to $396000.0 in 2024, then soared by 244.19% to $1.4 million in 2025, then soared by 303.52% to $5.5 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $5.5 million, $4.9 million, and $1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.50 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 396,000.00 |
| Sep 30, 2024 | 519,000.00 |
| Jun 30, 2024 | 986,000.00 |
| Mar 31, 2024 | 757,000.00 |
| Dec 31, 2023 | 825,000.00 |
| Sep 30, 2023 | 663,000.00 |
| Jun 30, 2023 | 517,000.00 |
| Mar 31, 2023 | 433,000.00 |
| Dec 31, 2022 | -51,000.00 |
| Sep 30, 2022 | 159,000.00 |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 464,000.00 |
| Dec 31, 2021 | 1.39 Mn |
| Sep 30, 2021 | 1.07 Mn |